Literature DB >> 53111

35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.

J H Lazarus, B Marchant, W D Alexander, D H Clark.   

Abstract

35S-methimazole (MMI), 35S-carbimazole or 35S-propylthiouracil (PTU) were given orally to fifty-five patients at various times up to 12 h before surgical thyroidectomy. The amount of 35S radioactivity and labelled drug in thyroid and plasma samples was measured. Intrathyroidal inhibition or organic binding of iodine by MMI, carbimazole and PTU was measured after intravenous administration of 131I, 132I or 125I-iodide. After administration of 35S-carbimazole or 35S-MMI the thyroid to serum (T/S) ratio of 35S radioactivity was greater in thyrotoxic glands than in non-toxic adenoma tissue. 35S-MMI was found in thyroid and plasma samples after administration of 35S-carbimazole. The T/S 35S-MMI was greater than 1 in most but not all patients. 35S radioactivity was also concentrated in the thyroid after administration of 35S-PTU. In thyrotoxic glands there was an 80% inhibition of iodine organification in patients receiving MMI and 60% for those receiving PTU. It is suggested that carbimazole and MMI can be given once or twice daily in some patients but PTU would be less suitable for this dose schedule.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53111     DOI: 10.1111/j.1365-2265.1975.tb01930.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity?

Authors:  L Takorabet; A Ropars; L Stasiuk; C Raby; J Charreire
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.

Authors:  A Melander; B Hallengren; S Rosendal-Helgesen; A K Sjöberg; E Wählin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

Review 3.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

4.  Specificity of the immunosuppressive action of carbimazole in Graves's disease.

Authors:  A M McGregor; B Rees Smith; R Hall; P N Collins; G Franco Bottazzo; M M Petersen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

5.  Single daily dose methimazole treatment of hyperthyroidism.

Authors:  D J Bouma; H Kammer
Journal:  West J Med       Date:  1980-01

6.  Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages.

Authors:  M Messina; P Milani; L Gentile; A Monaco; C Brossa; M Porta; F Camanni
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

7.  Correlation between antithyroid effect and serum concentrations of propylthiouracil in patients with hyperthyroidism.

Authors:  J P Kampmann; J E Mølholm Hansen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

9.  Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis.

Authors:  A M McGregor; H K Ibbertson; B R Smith; R Hall
Journal:  Br Med J       Date:  1980-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.